Florence Menegaux

researcher

Born 1972-01-01

Florence Menegaux is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID0647145701.51
P269IdRef ID083449019
P213ISNI0000000357139663
P496ORCID iD0000-0003-3363-6411
P1053ResearcherIDH-4261-2018
P10861Springer Nature person ID0647145701.51
P214VIAF ID196049018

P184doctoral advisorJacqueline ClavelQ30830766
P69educated atFrench National Institute of Health and Medical ResearchQ1474517
P108employerFrench National Institute of Health and Medical ResearchQ1474517
P735given nameFlorenceQ950780
FlorenceQ950780
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q37192589A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
Q57818346Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study
Q100426881Adiposity and endometrial cancer risk in postmenopausal women: a sequential causal mediation analysis
Q99545000African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
Q57305944Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Q63966080Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Q64118820Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Q60907509Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Q55466745Birth characteristics and childhood malignant central nervous sytem tumors: the ESCALE study (French Society for Childhood Cancer).
Q37379187Birth-related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: the ESCALE study (SFCE).
Q97436075Body mass index trajectories and prostate cancer risk: Results from the EPICAP study
Q51080101Breast cancer risk, nightwork, and circadian clock gene polymorphisms.
Q58317441Breast-feeding, fetal loss and childhood acute leukaemia
Q43979043Childhood acute leukemia, early common infections, and allergy: The ESCALE Study
Q45407709Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE).
Q46801325Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy
Q38854624Circadian Disruption and Prostate Cancer Risk: An Updated Review of Epidemiological Evidences
Q91145257Circadian genes and risk of prostate cancer: Findings from the EPICAP study
Q96162766Circadian genes polymorphisms, night work and prostate cancer risk: findings from the EPICAP study
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q24676459Day care, childhood infections, and risk of neuroblastoma
Q36623920Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study
Q35098158Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France
Q39727322Estimation of breast, prostate, and colorectal cancer incidence using a French administrative database (general sample of health insurance beneficiaries).
Q36720821Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37001227Familial history of cancer and childhood acute leukemia: a French population-based case-control study
Q58317442Family cancer history and risk of childhood acute leukemia (France)
Q34172056Family history of autoimmune thyroid disease and childhood acute leukemia
Q58317427Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: The ESCALE study (SFCE)
Q55311842Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q29417068Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q52720511Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.
Q47125417Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
Q58611475Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q36144176Household exposure to pesticides and risk of childhood acute leukaemia.
Q28382915Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE study (SFCE)
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q34038964Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
Q63604269Incidence of childhood leukaemia and non-Hodgkinʼs lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990–1999
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q34898735Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q58317429Maternal alcohol and coffee drinking, parental smoking and childhood leukaemia: a French population-based case?control study
Q58317437Maternal coffee and alcohol consumption during pregnancy, parental smoking and risk of childhood acute leukaemia
Q49722295Night shift work and breast cancer: a pooled analysis of population-based case-control studies with complete work history.
Q39850850Night work and breast cancer risk defined by human epidermal growth factor receptor-2 (HER2) and hormone receptor status: A population-based case-control study in France
Q45346343Night work and breast cancer: a population-based case-control study in France (the CECILE study).
Q57565039Night work and prostate cancer risk: results from the EPICAP Study
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q42373340Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q24651277Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy and childhood malignant central nervous system tumours: the ESCALE study (SFCE)
Q57734278Positive association between congenital anomalies and risk of neuroblastoma
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q88478329Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP study
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q114677146Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Q43051933Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.
Q36539428Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE).
Q63604277[What do interns in Public Health of Ile-de-France (IDF) do during their internship?]

Q30830766Jacqueline Claveldoctoral studentP185

Search more.